Positron emission tomography predicts survival in malignant pleural mesothelioma  Raja M. Flores, MD, Timothy Akhurst, MD, Mithat Gonen, PhD, Maureen Zakowski,

Slides:



Advertisements
Similar presentations
The prognostic importance of the number of involved lymph nodes in esophageal cancer: Implications for revisions of the American Joint Committee on Cancer.
Advertisements

Of mice and men and surgical transcatheter aortic valve insertion
Prognostic Factors in the Treatment of Malignant Pleural Mesothelioma at a Large Tertiary Referral Center  Raja M. Flores, MD, Maureen Zakowski, MD, Ennapadam.
Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Manuel J. Antunes, MD, PhD, DSc 
Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma  Kimberly S. Grant, MD,
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
Right internal thoracic artery or saphenous vein grafting
Intrinsic cardiac stem cells are essential for regeneration
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Abracadabra I, II…HeartMate 3?
Nael Martini, MDa, Manjit S. Bains, MDa, Michael E
Victor van Berkel, MD, PhD 
William M. DeCampli, MD, PhD 
The prognostic importance of the number of involved lymph nodes in esophageal cancer: Implications for revisions of the American Joint Committee on Cancer.
What is the best approach for surgery of malignant pleural mesothelioma? It is to put our efforts into obtaining trustworthy evidence for practice  Tom.
The lord of the rings  Antonio Miceli, MD, PhD 
Utility of Routine PET Imaging to Predict Response and Survival After Induction Therapy for Non-Small Cell Lung Cancer  Stephen A. Barnett, MBBS, Robert.
Gastric conduit revision after esophagectomy: The raising of Lazarus
The variability of the mitral valve anatomy and terminology
Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non–small cell.
Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.
Support Your Specialty
Innovation and science: The future of valve design
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
Military surgeons just want to have fun
A first start for lung transplantation?
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients  Raja.
Shawn S. Groth, MD, MS, R. Taylor Ripley, MD, Bryan M. Burt, MD 
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Yusuke Takahashi, MD, PhD, Prasad S. Adusumilli, MD 
Are discordant positron emission tomography and pathological assessments of the mediastinum in non–small cell lung cancer significant?  Daniel J. Tandberg,
Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow?  Jules Lin, MD  The Journal of Thoracic and Cardiovascular.
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
Prognostic Factors in the Treatment of Malignant Pleural Mesothelioma at a Large Tertiary Referral Center  Raja M. Flores, MD, Maureen Zakowski, MD, Ennapadam.
Is parameter T staging influenced by tumor behavior?
The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: Implications for revision of the.
Instrumental variable methods in clinical research
Attachment disorder in thoracoabdominal surgery
Case reporter's notebook: The who, what, when, where, how, and why of extraction of a benign intracaval tumor  Verdi J. DiSesa, MD, MBA  The Journal of.
We are the company we keep: The importance of the tumor microenvironment  Sai Yendamuri, MD, FACS  The Journal of Thoracic and Cardiovascular Surgery 
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Biomaterials for heart valve replacement: Conjectures and refutations
Prognosis and “granularity”: Building on staging foundations?
Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma  Kimberly S. Grant, MD,
Bernard J. Park, MD, Raja M. Flores, MD, Valerie W. Rusch, MD 
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
The continuing challenge of congenital heart disease in China
When should the elephant (frozen elephant trunk) enter the room (aorta)?  Frank A. Baciewicz, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume.
Ralph E. Delius, MD  The Journal of Thoracic and Cardiovascular Surgery 
Raja M. Flores, MD  The Journal of Thoracic and Cardiovascular Surgery 
After neoadjuvant chemoradiation therapy, predicted pulmonary function may be reduced by 10%  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular.
Therapeutic R2 resection for pleural mesothelioma
“The more things change…”: The challenges ahead
Raja M. Flores, MD, Bernard J
Toward a more rational approach in treating type B aortic dissection
First in line for robotic surgery: Would you want to know?
Ryan R. Davies, MD  The Journal of Thoracic and Cardiovascular Surgery 
Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery  Raja M. Flores, MD  The Journal.
Preoperative PFTs: The answer is blowing in the wind
Of mice and men… The Journal of Thoracic and Cardiovascular Surgery
Who should decide margin length in pulmonary excision of lung cancer?
Did you like Terminator 3 better than Terminator 2
Journal changes and initiatives
Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”
Deciding how much to pay for effective care
Presentation transcript:

Positron emission tomography predicts survival in malignant pleural mesothelioma  Raja M. Flores, MD, Timothy Akhurst, MD, Mithat Gonen, PhD, Maureen Zakowski, MD, Joseph Dycoco, BA, Steven M. Larson, MD, Valerie W. Rusch, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 132, Issue 4, Pages 763-768 (October 2006) DOI: 10.1016/j.jtcvs.2006.03.068 Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Hazard function plotting predicted median survival by SUV. SUV, Standard uptake value. The Journal of Thoracic and Cardiovascular Surgery 2006 132, 763-768DOI: (10.1016/j.jtcvs.2006.03.068) Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Overall survival by histology. The Journal of Thoracic and Cardiovascular Surgery 2006 132, 763-768DOI: (10.1016/j.jtcvs.2006.03.068) Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Overall survival by stage. TNM, Tumor node metastasis. The Journal of Thoracic and Cardiovascular Surgery 2006 132, 763-768DOI: (10.1016/j.jtcvs.2006.03.068) Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Overall survival by PET SUV. SUV, Standard uptake value. The Journal of Thoracic and Cardiovascular Surgery 2006 132, 763-768DOI: (10.1016/j.jtcvs.2006.03.068) Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 Overall survival by SUV and histology. SUV, Standard uptake value. The Journal of Thoracic and Cardiovascular Surgery 2006 132, 763-768DOI: (10.1016/j.jtcvs.2006.03.068) Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions